Accueil>>Signaling Pathways>> Apoptosis>>Flavokawain A

Flavokawain A (Synonyms: Flavokavain A, 4-methoxy Flavokawain B)

Catalog No.GC60845

La flavokawaÏne A, un agent anticancérogène prometteur, est une chalcone issue de l'extrait de kava avec une activité anti-tumorale. La flavokawaÏne A induit l'apoptose cellulaire par l'implication de la voie apoptotique dépendante de la protéine Bax et dépendante des mitochondries. La flavokawaÏne A a le potentiel pour l'étude du cancer de la vessie.

Products are for research use only. Not for human use. We do not sell to patients.

Flavokawain A Chemical Structure

Cas No.: 3420-72-2

Taille Prix Stock Qté
10mM (in 1mL DMSO)
50,00 $US
En stock
50mg
45,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Flavokawain A, a proming anticarcinogenic agent, is a chalcone from kava extract with anti-tumor activity. Flavokawain A induces cell apoptosis by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway. Flavokawain A has the potential for the study of bladder cancer[1].

[1]. Xiaolin Zi, et al. Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Res. 2005 Apr 15;65(8):3479-86.

Avis

Review for Flavokawain A

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Flavokawain A

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.